Introduction
Depending on the substrate used for isolation, genetically distinct influenza viruses are derived in the laboratory from human clinical material (Robertson et al., 1985 Katz & Webster, 1988) . Influenza A (H 1N 1), A (H3N2) and B viruses derived by mammalian tissue culture, i.e. in MDCK cells, generally differ from viruses derived from the same specimen in the allantoic cavity of embryonated hens' eggs at one of several distinct amino acid residues in the haemagglutinin (HA) molecule. These are located in the region of the receptor-binding site (RBS) at the tip of the HA molecule, suggesting that variants are selected on the basis of altered receptor specificity. Distinct variants can be derived in the egg from samples obtained during an epidemic, from samples obtained from a single person, from a single sample and from a single plaque on MDCK cells (Robertson et al., 1985 Katz & Webster, 1988; Wang et al., 1989) . That variants are selected from MDCK cell-grown virus in eggs, but not vice versa, suggests that the embryonated egg is a restrictive system The nucleotide sequence data reported in this paper have been submitted to the EMBL database and assigned the accession number X59778.
whereas MDCK cells are permissive for the different laboratory-derived viruses observed.
Recently, by using the polymerase chain reaction (PCR) (Saiki et al., 1988) to examine the sequence of HA1 of influenza B viruses present in clinical material, we have determined that the influenza B virus derived on MDCK cells is representative of the natural virus present in clinical material, and that isolating virus in the allantoic cavity selects several variants represented in the natural population only at very low levels . Also using PCR, Katz et al. (1990) have determined that the HA of influenza A (H3N2) virus present in clinical material is produced by virus isolated on cells, whereas a variant is selected in eggs. In contrast, Rajakumar et al. (1990) have found that the HA1 region of an influenza A (H1N1) virus which had undergone limited passage in the egg was identical to that of virus present in the original clinical sample, as determined by direct sequencing of PCR-amplified material. We have now performed a comprehensive PCR and cloning analysis of clinical material containing influenza A (H1N1) viruses and of the corresponding laboratoryderived viruses.
Amino acid substitutions associated with the adaptation of influenza A (H 1N 1) viruses to growth in eggs have been previously identified at residues 163, 187, 189, 190 or 225 of the HA molecule (H3 numbering) . Generally, egg-adapted viruses contain only one of these substitutions, some of which can have a dramatic effect on the antigenicity and immunogenicity of the virus Wood et al., 1989) , and may compromise the use of an eggadapted virus in seroepidemiological studies and for vaccine production. To determine the extent to which such variants are present in clinical material, we have amplified enzymically and cloned into M13 the HA1 coding region of influenza A (H 1N 1) viruses of different passage history, and analysed many individual clones. We have determined that the natural influenza A (H1N I) virus present in clinical material is represented by tissue culture-derived virus and that the variants observed by isolation in the egg are present in clinical specimens only at very low levels.
Methods
Virus isolation, propagation and antigenic characterization. Clinical specimens were obtained from distinct local outbreaks of influenza in the U.K. during the 1988 to 1989 winter season. Influenza A (H1NI) viruses were isolated in the laboratory from three specimens by inoculation either directly onto MDCK cells or into the amniotic cavity of embryonated hens' eggs, and passaged until haemagglutination was observed. For passage in the allantoic cavity, virus grown in the amniotic sac or MDCK cell-derived virus was inoculated at dilutions of 10 ° to 10 -3, and virus was harvested at the greatest dilution of inoculum at which haemagglutination was observed.
Ferret antisera were obtained from ferrets infected intranasally and bled 10 days later. Haemagglutination inhibition (HI) assays were performed in microtitre plates by standard methods using turkey erythrocytes and antisera treated with receptor-destroying enzyme.
Reverse transcription and amplification of the HA gene. Clinical material, infectious tissue culture fluid or allantoic fluid (200 p.1) was treated with 50 ~tg/ml proteinase K in 10 mM-Tris-HC1 pH 7.5, 5 mM-EDTA, 0.5% SDS at 37 °C for 30 min. Samples were extracted once with phenol/chloroform and twice with chloroform, and nucleic acid was precipitated using ethanol with glycogen as carrier. Precipitated nucleic acid was resuspended for reverse transcription in 101al of 100 mM-Tris HCI pH 8.3, 10 mM-MgCI2, 140 mM-KCI, 10 mM-DTT, 400 I.tM-dNTPs and 2 to 3 pmol either primer A/5/1 (AAAGCAG-GGGAAAATAAAAACAACC) or Bam/A/52/1 (GCGTATG-GATCCTGTTATGTGCATTTACAG), which are specific for the 3' end of the viral RNA HA segment. The Bam/A/52/1 primer has a BamHI site built into it (underlined). Avian myeloblastosis virus reverse transcriptase [7.5 units (U); Life Sciences Inc.] was added, and the reaction was incubated at 42 °C for 60 min and terminated by boiling for 1 min.
The cDNA corresponding to the HA1 coding region was amplified enzymically in a 100 ~tl PCR containing 10 mM-Tris-HCl pH 8.3, 3 mM-MgCI2, 50 mM-KC1, 0.01% (w/v) gelatin, 0.1 ~tM-primers, 200 ].tM-dNTPs and 2.5 U Taq polymerase (Perkin-Elmer Cetus), overlaid with paraffin oil and subjected to 30 cycles of 94 °C for 0-5 min, 55 °C for 0.5 min and 72 °C for 1.0 rain (Saiki et al., 1988) . The primers used for the amplification were either A/5/1 with A/1117/2 (ATCATTCCAGTC-CATCCCCCTTCAAT) or Barn/A/52/1 with Eco/A/ll09/2x (ACT-GACGAATTCCAGTCCATCCCCCTTC). The Eco/A/ll09/2x primer has an EcoRI site built into it (underlined). After amplification, 5 ktl of each reaction was analysed by agarose gel electrophoresis and the DNA was visualized by ethidium bromide staining.
All extractions, cDNA syntheses and amplifications were accompanied by controls in which water replaced the sample being analysed, including a control which was co-processed through every manipulation. All pre-amplification manipulations were performed in a laboratory separate from that used for post-amplification work.
Cloning and sequencing. Following amplification, samples were extracted with ether, phenol/chloroform and chloroform, and the DNA was fractionated on either Sepharose 4B (Pharmacia) or through SizeSelect-400 Spun Columns (Pharmacia). The amplified DNA was ethanol-precipitated and double-digested with BamHI and EcoRI (New England Biolabs). DNA was then ligated into BamHI-and EcoRI-digested M13mpl8 vector and used to transform competent J M 101 cells in the presence of 5-bromo-4-chloro-3-indolyl-fl-D-galactopyranoside and IPTG (Sambrook et al., 1989) . Recombinant virus plaques were picked and grown, and MI3 DNA was prepared, all by standard procedures. Phages containing inserts were identified by agarose gel electrophoresis and sequenced by the dideoxynucleotide chain termination method (Sanger et al., 1977) using T7 DNA polymerase (Pharmacia) with either the universal MI3 sequencing primer or primers specific for internal regions of the inserted HA segment. Sequencing products were separated on 8% sequencing gels and the data analysed by computer using the Staden (1982) and GCG (Devereux et al., 1984) programs.
Results
Three influenza A (H1N1) virus specimens, A/NIB/4/88 (Nib4), A/NIB/49/88 (Nib49) and A/NIB/23/89 (Nib23), obtained from within the U.K. during the 1988 to 1989 winter season, were studied. For each specimen there were three virus samples, i.e. original clinical material, MDCK-cell-derived virus and egg-adapted virus (Table 1) , obtained as described in Methods. The Nib49 clinical specimen (Nib49cs) apparently contained very low titres of virus because haemagglutination was not obtained until after a second blind passage on MDCK cells and an egg-adapted virus could not be obtained directly in the egg. The egg-adapted Nib49 Clinical influenza A (HIN1) HA sequences 2673 (Table 1) . For each of the egg-adapted viruses, the allantoic fluid analysed was obtained from a single egg.
The viruses employed in this study were characterized antigenically using an HI assay with ferret antisera generated against five egg-adapted influenza A (H1N1) viruses and a monoclonal antibody (MAb 550) ( Table 2) . These data show that the Nib viruses are antigenically similar to each other and to other recent influenza A (H 1N 1) isolates, and distinct from viruses isolated prior to the appearance of A/Taiwan/1/86. Significantly, the ferret antiserum raised against A/Dunedin/27/83 was able to discriminate between MDCK cell-derived and egg-adapted Nib viruses, this serum failing to react with the MDCK cell-derived isolates. MAb 550, raised against an influenza A (H1N1) virus derived in MDCK cells in 1983 (Yates et al., 1990) , showed variable reactivity with the five prototype strains. In addition, it reacted to low titre with the cell-isolated Nib viruses and not at all with the egg-adapted viruses.
To examine any heterogeneity within the HA genes of the various virus samples, we amplified the HA1 coding region using the PCR technique and cloned the amplified DNA into M13. Complementary DNA was synthesized using one of two primers specific for the 3' end of the HA segment; these were A/5/1, which is entirely complementary, or Bam/A/52/1. For all but two of the samples, Nib49cs and Nib23E, cDNA was amplified in a single step using the restriction site primers Bam/A/52/1 and Eco/A/1109/2x, which facilitated direct cloning into M13. The 1058 bases amplified encompass the entire HA 1 coding region of the HA gene. The cDNAs corresponding to Nib49cs and Nib23E were successfully amplified following the nested primer approach (Mullis & Faloona, 1987) using primers A/5/1 and A/1117/2 in the first amplification (30 cycles), and Bam/A/52/1 and Eco/A/1109/2x in the second amplification (30 cycles). This further suggested that Nib49cs had a very low titre of virus. For Nib23E, a very faint band of DNA was observed after the first amplification which was strongly amplified in the second round. It was surprising that the HA1 region of Nib23E, which had an HA titre of 256, was not adequately amplified after the first amplification.
We have previously shown that specific amino acid substitutions occur in the HA of egg-adapted influenza A (H1N1) viruses at HA1 residues 163, 187, 189, 190 and 225. To determine to what extent each virus sample contained one or more of these variants, a region of about 250 nucleotides of the insert encoding these amino acid residues was analysed for 30 clones of each virus sample. In addition, the sequence of the entire 1058 base insert was determined for at least one clone from each virus sample. Substitutions which occurred in the codons of any of the above 'egg-adapted' residues, or occurred elsewhere in the insert in at least two of the M13 clones derived from a single virus sample, are shown in Table 3 . Substitutions which occurred in only a single clone of a virus sample, and not at any of the above residues, are not shown. These are likely to have arisen from errors introduced during the transcription and amplification procedures (see below and Discussion).
For Nib4, two of 30 clones derived from the clinical specimen had a substitution at one of the 'egg-adapted' residues, one at residue 163 and one at residue 190; the remainder had none (Table 3) . No substitutions were detected in the clones derived from Nib4M. For Nib4E, 22 of 30 clones had a substitution of Gty for Asp at (Table 3 ). All 30 Nib49E-derived clones had this same substitution at position 190, and two of them had an additional substitution, one at position 163 (Asn-,Tyr) and one at position 225 (Asp-,Gly).
For Nib23, all 30 clones derived from Nib23cs and 28 of 30 from Nib23M had no substitutions (Table 3) . One of the clones from Nib23M had a substitution of Ser for Asn at residue 163 and one had a base deletion in the codon for residue 190. For Nib23E, 28 of 30 clones had a substitution of Asn for Asp at residue 190, one clone also had a substitution of Ser for Asn at residue 187, and two clones had no substitutions at any of the 'egg adaptation' positions. One of these two clones had a single, silent mutation (A-,T) at position 948. The other clone differed from the consensus sequence at bases 136, 424 and 937, which resulted in substitutions of residues 35 (T-,A), 125c (S--,G) and 294 (F--,L).
In addition to the substitutions shown in Table 3 , 71 substitutions and two deletions were detected in 90935 bases analysed. On two occasions, an identical substitution was found in two clones derived from the same virus sample, but in both cases these were silent mutations. The remaining 67 substitutions occurred only once within a virus sample and were distributed evenly between samples, with the exception of Nib49E in the clones of which only two substitutions were observed in the 8140 bases analysed. One-third of the 71 substitutions were silent mutations. Most of the substitutions (63 of 71) were transitions, and of these 55 were A :T-,G :C, with twice as many A-,G substitutions as T-,C.
The consensus HA 1 nucleotide sequences for each of viruses Nib4, Nib49 and Nib23 were distinct. The Nib4 viruses all had a G residue at positions 126 and 453. The Nib49 and Nib23 viruses were characterized by having a T residue at position 264, a C residue at positions 504 and 804, whereas the Nib49 viruses had a T residue at position 891. None of these nucleotide differences between the three sets of viruses affected the encoded amino acid and the deduced amino acid sequences of HA1 of Nib4M, Nib49M and Nib23M viruses are identical (Fig. 1) . ........................................ .
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328 GECPKYVRST KLRMVTGLR~I IPSIQS Fig. 1 . Deduced amino acid sequences for HAl of Nib4cs and Nib4M, and for A/Taiwan/1/86 (Robertson, 1987; Cox et al., 1989) . H3 numbering is used.
Discussion
We have analysed the nucleotide sequence encoding HA 1 of influenza viruses present in clinical material, and compared them with that of MDCK cell-derived and egg-adapted viruses. We can conclude from this study that for the influenza A (H 1 N 1) subtype virus isolated in the laboratory on MDCK cells, and not an egg-grown virus, is representative of the natural virus present in clinical material, that the HA of virus present in clinical material or isolated in the laboratory on MDCK cells is relatively homogeneous, and that more than one eggadapted variant may be present in a virus sample derived from a single egg.
Previously we have described substitutions which accompany adaptation of influenza A (H1N1) viruses to growth in eggs, at HA1 residues 163, 187, 189, 190 and 225, mapping around the RBS of HA . In this study we observed substitutions at residues 129, 163, 187, 190, 225 and 226 of the HA1 of eggadapted virus (Table 3 ; Fig. 2 ). Substitution at residue 189 is now unlikely to occur because it would require two base substitutions in current influenza A (H 1N 1) viruses to substitute the amino acid residue (Lys) observed previously at this position in egg-adapted viruses. Two additional amino acid substitutions associated with adaptation to growth in eggs have been identified in this study. For Nib4E, one-sixth of the clones had a substitution of Lys for Ash at residue 129, which results in the loss of a potential glycosylation site, and two clones had a substitution of Arg for Gln at position 226. Residue 129 is not located in the immediate vicinity of the RBS; however, if the natural and MDCK cell-grown viruses are glycosylated at this position, the loss of a carbohydrate structure could potentially affect the RBS in a steric manner (Fig. 2) . Residue 129 has been shown elsewhere to be associated with altered host range and receptorbinding properties (Aytay & Schulze, 1991) . Residue 226 163 Fig. 2 . ceCarbon tracing of the H3 subtype HA molecule (Wilson et al., 1981) indicating the location of residues associated with adaptation of influenza A (H1N1) viruses to growth in eggs. Data from this report and Robertson et al. (1987) . H3 numbering is used.
is directly adjacent to the RBS (Fig. 2) , and has also been shown to alter receptor binding in the H1 subtype (Nobusawa & Nakajima, 1988) and receptor specificity in the H3 subtype (Rogers et al., 1983) .
Owing to base misincorporation by the polymerases employed in this study, the significance of a substitution which occurs in only a single clone is difficult to assess and it cannot be assumed that such a variant existed in the original virus population. Nib4cs gave rise to single clones with a substitution at position 163 or 190, neither of which was detected in either the clones of Nib4M or Nib4E. If these changes were present in the original clinical sample at a frequency of 1 in 30 then it would be anticipated that one or both of these viruses would have grown successfully in eggs, as is the case for Nib49, and so these are more likely to be due to a cloning artefact.
Also, the change at position 190 in the Nib4cs clone (Asp--,Gly) is different from the change usually observed at this position during adaptation to growth in eggs (Asp~Asn)  Table 3) . Similarly, Nib23M also had a single clone with a substitution at position 163 which was not observed in the clones from the clinical material or the egg-adapted virus. However, the substitution of Asn for Asp at position 190 in a single clone of Nib49cs was present in all clones of the corresponding egg-adapted virus, although not in those from the MDCK cell-grown virus despite Nib49E having been derived from Nib49M.
The significance to adaptation to growth in eggs of clones, one from Nib23E and two from Nib49E, which had substitutions at position 190 and at an additional 'egg-adapted' site can not be assessed from the data available. Such additional substitutions, and the deletion of a base in the codon for residue 190 in a Nib23M clone, are more likely to be artefacts, e.g. Taq polymerase errors. Two egg-adapted clones, one from Nib4E and one from Nib23E, had no substitutions in their entire HA1 sequence and this may indicate limited replication of the natural virus in the allantoic cavity. Another Nib23E clone had no substitutions at any of the 'egg-adapted' positions, but had three base differences which resulted in coding changes at HA1 positions 35, 125c and 294. Of these, only residue 125c is in the vicinity of the RBS.
Several different egg variants were found in this study. The particular egg variant(s) that has grown successfully is likely to be a reflection of the virus population in the inoculum and not the HAl structures of the natural viruses because these are identical for the three viruses studied. The extent to which different egg-adapted variants might be more successful than others in growing in the egg can not be assessed from our data and is under further investigation. The level of variation in natural and MDCK cell-grown virus is unknown and may be as low as 10 -4 to 10 -5, the frequency of occurrence of MAb escape mutants which contain single amino acid substitutions in their HA (Portner et al., 1980) , or as high as 10 -1 to 10 -2, as suggested by our data on Nib49cs.
In addition to those shown in Table 3 , we detected 71 base substitutions in the 90935 bases compared, i.e. 1 per 1282, and two point deletions. This gives a mutation rate of 0.5 x 10 -4 (calculated according to Saiki et al., 1988) and is comparable to that for a similar study of influenza B viruses . The three polymerases most likely to be responsible for such base substitutions, i.e. the influenza virus polymerase, the reverse transcriptase and the Taq polymerase, have misincorporation rates of 0.15 x 10 -4 (Parvin et al., 1986) , 3 x 10 -4 (Fields & Winter, 1981) , and 1 x 10 -4 to 2 x 10 -4 (Saiki et al., 1988; Tindall & Kunkel, 1988 ) respectively, i.e. the probability that the enzymes utilized in the laboratory introduce substitutions is at least 10-fold that of viral polymerase. The predominance of A :T--,G :C transitions observed in this study (55 of 63) is characteristic of Taq polymerase (Saiki et al., 1988; Tindall & Kunkel, 1988) , although the excess of A--,G transitions (37) over T~C transitions (18) suggests that a significant number of them arose during the asymmetric reverse transcription step rather than the symmetric DNA amplification stage. Also, there was no increase in errors in the clones derived from Nib23E and Nib49cs, which went through 60 cycles of amplification rather than 30.
The three isolates originated during an outbreak of influenza in the U.K. in December 1988 from three centres, each a few hundred miles apart. Although the HA1 coding regions were not identical, the deduced amino acid sequences were identical and are shown in comparison to A/Taiwan/1/86 in Fig. 1 . Antigenic drift has occurred at residues 82, 142, 160 and 210, all of which could potentially affect antigenicity, especially the change at residue 160 which results in the loss of a glycosylation site from the tip of the HA molecule. The difference at residue 225 is likely to be due to adaptation of A/Taiwan/l/86 (Robertson, 1987) to growth in eggs. The egg-and cell-derived viruses analysed in this study could be distinguished antigenically by one of the ferret antisera and by MAb 550. MAb 550 belongs to a group of antibodies described by Yates et al. (1990) the HI reactivity of which is affected by residues 187, 189 and 225.
In contrast to this report, Rajakumar et al. (1990) reported identity between the HA 1 sequence of allantoic virus and the virus present in clinical material. However, if several different variants were present in their allantoic sample, the sequence differences may have gone undetected because the amplified DNA was sequenced directly without subcloning. Findings similar to those in this report have been found for influenza B and A (H3N2) viruses Katz et al., 1990) . Thus, all currently circulating subtypes of human influenza viruses undergo selection when propagation is performed in embryonated hens' eggs, whereas the natural virus is correctly represented by isolation and propagation on a mammalian cell line, MDCK. In addition, antigenic and immunogenic differences between the HAs of egg-adapted and MDCK cellderived viruses have been demonstrated for all these subtypes. Since the majority of antigenic and serological studies are performed using egg-adapted viruses, care must be exercised in the interpretation of data.
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